| Name | Walgreen Store #6999 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 173 S Main St, Alpharetta, Georgia 30009 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (678) 297-9178 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
During the COVID-19 pandemic, every frequently touched surface outside our home seems as dangerous as a hot pot right out of the oven. We won't get burned if we touch it, but we might get infected with a potentially dangerous virus.
LEAD Therapeutics, a privately held drug discovery company, announced the discovery of a novel antibiotic with potent activity against many of the most common antibiotic resistant bacteria.
Among patients with melanoma, those who received both ipilimumab (Yervoy) and local peripheral treatments such as radiotherapy or electrochemotherapy had significantly prolonged overall survival compared with those who received only ipilimumab, according to a retrospective clinical study.
Using high-precision genetic tests to differentiate the thousands of bacteria that make up the human microbiome, researchers at NYU Langone Medical Center suggest that they have found a possible — and potentially surprising — root cause of the increased frequency of certain eye infections among contact lens wearers.
OncoSynergy announced today that the FDA Office of Orphan Products Development has granted orphan drug designation for the investigational drug candidate OS2966, a neutralizing anti-CD29 monoclonal antibody, for the treatment of glioblastoma, the most common and deadliest primary adult brain tumor.
› Verified 3 days ago
| NPI Number | 1669487872 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #06999 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 173 S Main St, Alpharetta, GA 30009 |
| Phone Number | 678-297-9048 |
News Archive
During the COVID-19 pandemic, every frequently touched surface outside our home seems as dangerous as a hot pot right out of the oven. We won't get burned if we touch it, but we might get infected with a potentially dangerous virus.
LEAD Therapeutics, a privately held drug discovery company, announced the discovery of a novel antibiotic with potent activity against many of the most common antibiotic resistant bacteria.
Among patients with melanoma, those who received both ipilimumab (Yervoy) and local peripheral treatments such as radiotherapy or electrochemotherapy had significantly prolonged overall survival compared with those who received only ipilimumab, according to a retrospective clinical study.
Using high-precision genetic tests to differentiate the thousands of bacteria that make up the human microbiome, researchers at NYU Langone Medical Center suggest that they have found a possible — and potentially surprising — root cause of the increased frequency of certain eye infections among contact lens wearers.
OncoSynergy announced today that the FDA Office of Orphan Products Development has granted orphan drug designation for the investigational drug candidate OS2966, a neutralizing anti-CD29 monoclonal antibody, for the treatment of glioblastoma, the most common and deadliest primary adult brain tumor.
› Verified 3 days ago
News Archive
During the COVID-19 pandemic, every frequently touched surface outside our home seems as dangerous as a hot pot right out of the oven. We won't get burned if we touch it, but we might get infected with a potentially dangerous virus.
LEAD Therapeutics, a privately held drug discovery company, announced the discovery of a novel antibiotic with potent activity against many of the most common antibiotic resistant bacteria.
Among patients with melanoma, those who received both ipilimumab (Yervoy) and local peripheral treatments such as radiotherapy or electrochemotherapy had significantly prolonged overall survival compared with those who received only ipilimumab, according to a retrospective clinical study.
Using high-precision genetic tests to differentiate the thousands of bacteria that make up the human microbiome, researchers at NYU Langone Medical Center suggest that they have found a possible — and potentially surprising — root cause of the increased frequency of certain eye infections among contact lens wearers.
OncoSynergy announced today that the FDA Office of Orphan Products Development has granted orphan drug designation for the investigational drug candidate OS2966, a neutralizing anti-CD29 monoclonal antibody, for the treatment of glioblastoma, the most common and deadliest primary adult brain tumor.
› Verified 3 days ago
Bio-tech Orthotic & Prothetic Servi Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4895 Windward Pkwy, Alpharetta, Georgia 30004 Phone: (404) 600-2072 | |
Cornerstone Medical Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2660 Holcomb Bridge Rd, Alpharetta, Georgia 30022 Phone: (770) 399-7337 | |
Cvs Pharmacy # 02185 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 184 N Main St, Alpharetta, Georgia 30009 Phone: (678) 297-1089 | |
Cvs Pharmacy # 02309 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3020 Windward Plz, Alpharetta, Georgia 30005 Phone: (770) 475-3638 | |
Cvs Pharmacy # 02539 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5740 Atlanta Hwy, Alpharetta, Georgia 30004 Phone: (678) 366-7954 |